We at Daiichi Sankyo want to protect the environment. Our German plant in Pfaffenhofen is a green…
100 Years of Innovation
From Tokyo to Munich, Paris, and Pfaffenhofen. Our corporate video provides you with an insight into our company, our Japanese roots, our global history and pathways to innovation and care for patients.
High blood pressure is one of the most common causes of cardiovascular diseases in the world.…
Our oral antiplatelet agent prasugrel2 helps to keep blood platelets from clotting together and…
Edoxaban is a once-daily, non-vitamin K antagonist (non-VKA) oral anticoagulant (NOAC) that…
We comply with laws, regulations and rules regarding global corporate activities, and act with the…
Daiichi Sankyo addresses patients, medical professionals, employees and health authorities as its…
European Structure
Daiichi Sankyo Europe GmbH is a wholly owned affiliate of Daiichi Sankyo Co., Ltd., which is headquartered in Tokyo. It is a limited liability company under German corporate law. read more…
Here you will find more information about our European manufacturing plants in Pfaffenhofen and…
With net sales of €590 million in fiscal year 2013, Europe is the third most important market for…
